Skip to main content

MoneyWorks4Me

Hikal informs about company updates

04 Nov 2019 Evaluate

Hikal has informed that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its API Unit located at Jigani, Bangalore for the inspection conducted in July 2019. The inspection resulted in one minor FDA Form 483 which was closed out immediately. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..